KaydedilenlerDerginizi ekleyin

Dergiler / Haseki Tıp Bülteni / 2021 / Cilt: 59 - Sayı: 3

Investigation of the Relationship Between IL-1Ra VNTR Variants and Psoriasis

Ayşegül Başak AKADAM TEKER
Burak AKSAN
Sayfa
245–248
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, the fact that all of our patients with psoriasis area andseverity index

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Psoriasis is an inflammatory skin disease characterized by hyperproliferation of keratinocytes.
📊
Temel Bulgular & Veri:The imbalance between Interleukin-1(IL-1)/IL-1 receptor antagonist (IL-1Ra) is associated with increased pro-inflammatory cytokine production and the development ofinflammatory disorders.
💡
Sonuç & Katkı:In addition, the fact that all of our patients with psoriasis area andseverity index
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Psoriasis is an inflammatory skin disease characterized by hyperproliferation of keratinocytes. The imbalance between Interleukin-1(IL-1)/IL-1 receptor antagonist (IL-1Ra) is associated with increased pro-inflammatory cytokine production and the development ofinflammatory disorders. The number of repeats in the polymorphic site where IL-1Ra has an 86 bp sequential repeat sequence isof functional importance as it includes possible binding sites for transcription factors. In this context, we aimed to investigate therelationship between psoriasis and IL-1Ra VNTR in Turkish society.Methods: One hundred twenty one patients (79 female/42 male), 250 controls (142 women/108 male) were included in thestudy groups and genotyped by polymerase chain reaction-restriction fragment length polymorphism method. Genotype and alleledistributions were examined between the patient and control groups. The gene counting method was used to calculate the allelefrequencies.Results: The A1 allele is excessive in the control group (p=0.001). In addition, the fact that all of our patients with psoriasis area andseverity index

🔖

Bu Makaleye Atıf Yap

TEKER, A. B. A., AKSAN, B. (2022). Investigation of the Relationship Between IL-1Ra VNTR Variants and Psoriasis. Haseki Tıp Bülteni, Cilt: 59 - Sayı: 3, 245–248. https://ajindex.com/articles/535136

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:121-8
  2. Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol 2007;28:51-7
  3. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007;445:866-73
  4. Elder JT, Nair RP, Henseler T, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol 2001;137:1447-54
  5. Enamandram M, Kimball AB. Psoriasis epidemiology: the interplay of genes and the environment. J Invest Dermatol 2013;133:287-9
  6. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999;1:3-19
  7. Mistry A, Savic S, van der Hilst JCH. Interleukin-1 Blockade: An Update on Emerging Indications. BioDrugs 2017;31:207-21
  8. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL- 1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-10
  9. Tarlow JK, Cork MJ, Clay FE, et al. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 1997;136:147-8
  10. Nakajima A, Matsuki T, Komine M, et al. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice. J Immunol 2010;185:1887-93
  11. Shepherd J, Little MC, Nicklin MJ. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol 2004;122:665-9
  12. Kim HJ, Kim SH, Park J, Lee M, Kim DS, Lee MG. Up-regulation of receptor antagonist interleukin-1 family members in psoriasis and their regulation by pro-inflammatory cytokines. J Dermatol Sci 2016;82:204-6
  13. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191-4
  14. Settin A, Abdel-Hady H, El-Baz R, Saber I. Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 2007;28:363-71
  15. Cai Y, Xue F, Quan C, et al. A Critical Role of the IL-1β-IL- 1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis. J Invest Dermatol 2019;139:146-56
  16. Di Paolo NC, Shayakhmetov DM. Interleukin 1α and the inflammatory process. Nat Immunol 2